AU2452197A - Genes amplified in cancer cells - Google Patents

Genes amplified in cancer cells

Info

Publication number
AU2452197A
AU2452197A AU24521/97A AU2452197A AU2452197A AU 2452197 A AU2452197 A AU 2452197A AU 24521/97 A AU24521/97 A AU 24521/97A AU 2452197 A AU2452197 A AU 2452197A AU 2452197 A AU2452197 A AU 2452197A
Authority
AU
Australia
Prior art keywords
cancer cells
genes amplified
genes
amplified
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24521/97A
Other languages
English (en)
Inventor
Ling-Chun Chen
Helene Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
California Pacific Medical Center
Original Assignee
California Pacific Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1996/009286 external-priority patent/WO1996039516A2/en
Priority claimed from US08/678,280 external-priority patent/US5776683A/en
Application filed by California Pacific Medical Center filed Critical California Pacific Medical Center
Publication of AU2452197A publication Critical patent/AU2452197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU24521/97A 1996-04-10 1997-04-09 Genes amplified in cancer cells Abandoned AU2452197A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US1516796P 1996-04-10 1996-04-10
US60015167 1996-04-10
WOUS9609286 1996-06-05
PCT/US1996/009286 WO1996039516A2 (en) 1995-06-05 1996-06-05 Targets for breast cancer diagnosis and treatment
US1920296P 1996-06-06 1996-06-06
US60019202 1996-06-06
US08678280 1996-07-11
US08/678,280 US5776683A (en) 1996-07-11 1996-07-11 Methods for identifying genes amplified in cancer cells
PCT/US1997/005930 WO1997038085A2 (en) 1996-04-10 1997-04-09 Genes amplified in cancer cells

Publications (1)

Publication Number Publication Date
AU2452197A true AU2452197A (en) 1997-10-29

Family

ID=27486464

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24521/97A Abandoned AU2452197A (en) 1996-04-10 1997-04-09 Genes amplified in cancer cells

Country Status (4)

Country Link
EP (1) EP0944651A2 (de)
JP (1) JP2000509256A (de)
AU (1) AU2452197A (de)
WO (1) WO1997038085A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170864A1 (en) 2000-05-30 2003-09-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7160985B2 (en) 1997-10-29 2007-01-09 Genentech, Inc. Pro180 polypeptide
US7351543B2 (en) 1998-06-02 2008-04-01 Genentech, Inc. Antibodies to a polypeptide encoded by a nucleic acid underexpressed in melanoma
US7319008B2 (en) 1998-06-02 2008-01-15 Genentech, Inc. Nucleic acid underexpressed in melanoma
US20030105298A1 (en) 1998-06-16 2003-06-05 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7244428B2 (en) 1998-09-10 2007-07-17 Genentech, Inc. PRO1357 antibodies
US7244817B2 (en) 1998-09-10 2007-07-17 Genentech, Inc. Pro1357 polypeptide
US7399828B2 (en) 1998-09-24 2008-07-15 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7402661B2 (en) 1998-10-06 2008-07-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
GB9827430D0 (en) * 1998-12-11 1999-02-03 Ludwig Inst Cancer Res Differential expression in primary breast cancer
US7232889B2 (en) 1999-03-08 2007-06-19 Genentech, Inc. PRO300 antibodies
US7507404B2 (en) 1999-03-08 2009-03-24 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7300758B2 (en) 1999-12-09 2007-11-27 Genetech, Inc. Nucleic acid underexpressed in esophageal tumor
US7288384B2 (en) 1999-12-09 2007-10-30 Genentech, Inc. Antibodies to polypeptides encoded by a nucleic acid underexpressed in esophageal tumor
US7423127B2 (en) 1999-12-09 2008-09-09 Genentech, Inc. Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
US20030018172A1 (en) 2001-12-06 2003-01-23 Genentech, Inc. Secreted transmembrane polypeptides and nucleic acids encoding the same
US7989167B2 (en) 2006-11-13 2011-08-02 Val-Chum L.P. Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968603A (en) * 1986-12-31 1990-11-06 The Regents Of The University Of California Determination of status in neoplastic disease
EP0444181B2 (de) * 1989-08-04 2010-11-24 Bayer Schering Pharma Aktiengesellschaft Äusserliche domäne von c-erbb-2:gp75
WO1992021771A1 (en) * 1991-06-03 1992-12-10 Triton Diagnostics, Inc. Epidermal growth factor receptor ectodomain

Also Published As

Publication number Publication date
JP2000509256A (ja) 2000-07-25
WO1997038085A2 (en) 1997-10-16
EP0944651A2 (de) 1999-09-29
WO1997038085A3 (en) 1998-02-19

Similar Documents

Publication Publication Date Title
AU7499198A (en) Gene expression profiles in normal and cancer cells
AU6024598A (en) Hybridization-based genetic amplification and analysis
AU2452197A (en) Genes amplified in cancer cells
AU3227497A (en) (patched) genes and their uses
AU1922301A (en) Differential gene expression in cancer
AU5691699A (en) Human genes differentially expressed in colorectal cancer
AU1805597A (en) Electrochemical cell
AU7476198A (en) Cell proliferation related genes
AU1520499A (en) Essential fungal genes and their use
AU2460097A (en) (mad)-related genes in the human
AU4551597A (en) Controlled gene expression in plants
AU3549799A (en) Mammalian selenoprotein differentially expressed in tumor cells
AU3228197A (en) Cell growth regulatory genes
AU6736598A (en) Methods for selecting cells and their uses
AU5474899A (en) Genes amplified in cancer cells
AU8074698A (en) (costal2) genes and their uses
AU2750197A (en) Dna replication-regulating genes
AU6578798A (en) Sugar-regulatory sequences in alpha-amylase genes
AU3349997A (en) Reg gene expression in cancer tissue
AU4860299A (en) (zap-3) tumor associated genes and their uses
AU5416700A (en) Differentially expressed genes in prostate cancer
AU1540395A (en) In situ nucleic acid amplification
AU2104497A (en) Cell stimulation
AU4328399A (en) Nucleic acid-cobalamin complexes and their use in gene therapy
AU1877697A (en) Electrochemical cell

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted